<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>1(3)</volume><submitter>Li H</submitter><pubmed_abstract>Vogt-Koyanagi-Harada (VKH) disease is a systemic autoimmune disorder threatening the eyesight. The pathogenic mechanisms and biomarkers reflecting disease severity and predicting treatment response require further exploration. Here, we performed a single-cell analysis of peripheral blood mononuclear cells (PBMC) obtained from eight patients with VKH disease and eight healthy controls to comprehensively delineate the changes in VKH disease. We showed a mixture of inflammation, effector, and exhausted states for PBMCs in VKH disease. Notably, our study implicated a newly identified B cell subset, natural killer-like B cells (K-BC) characterized by expressing CD19 and CD56, was correlated with VKH disease. K-BCs expanded in VKH disease, fell back after effective treatment, and promoted the di</pubmed_abstract><journal>Life medicine</journal><pagination>387-400</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11749541</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Peripheral immune landscape and natural killer-like B cells in human Vogt-Koyanagi-Harada disease.</pubmed_title><pmcid>PMC11749541</pmcid><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Huang Z</pubmed_authors><pubmed_authors>Zhu L</pubmed_authors><pubmed_authors>Xie L</pubmed_authors><pubmed_authors>Yang S</pubmed_authors><pubmed_authors>Chen B</pubmed_authors><pubmed_authors>Su W</pubmed_authors><pubmed_authors>Ye J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peripheral immune landscape and natural killer-like B cells in human Vogt-Koyanagi-Harada disease.</name><description>Vogt-Koyanagi-Harada (VKH) disease is a systemic autoimmune disorder threatening the eyesight. The pathogenic mechanisms and biomarkers reflecting disease severity and predicting treatment response require further exploration. Here, we performed a single-cell analysis of peripheral blood mononuclear cells (PBMC) obtained from eight patients with VKH disease and eight healthy controls to comprehensively delineate the changes in VKH disease. We showed a mixture of inflammation, effector, and exhausted states for PBMCs in VKH disease. Notably, our study implicated a newly identified B cell subset, natural killer-like B cells (K-BC) characterized by expressing CD19 and CD56, was correlated with VKH disease. K-BCs expanded in VKH disease, fell back after effective treatment, and promoted the di</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-05T11:34:17.346Z</modification><creation>2025-04-05T11:34:17.346Z</creation></dates><accession>S-EPMC11749541</accession><cross_references><pubmed>39872747</pubmed><doi>10.1093/lifemedi/lnac047</doi></cross_references></HashMap>